FIX vs GSK · P/E 32, rev $9.10B vs P/E 13, $103.31B cap
Comfort Systems USA Inc (FIX) versus GlaxoSmithKline PLC ADR (GSK) — a side-by-side from cached financials, not a winner call.
Comfort Systems USA Inc (FIX) is a engineering & construction company listed on US.
GlaxoSmithKline PLC ADR (GSK) is a drug manufacturers - general company listed on US.
Latest reported FIX revenue for 2025-12-31 was $9.10B. Net income was $1.02B. Revenue was up 29.5% from 2024-12-31 to 2025-12-31. FIX currently screens at market cap $19.10B and trailing P/E 32.5.
GSK does not have a complete income-statement cache yet.
FIX currently screens at market cap $19.10B and trailing P/E 32.5. GSK currently screens at market cap $103.31B and trailing P/E 13.5.
Not investment advice. Open the FIX and GSK stock pages for the full models.
Not investment advice.